STAT

JANUARY 9, 2024

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing. Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates.

145

145

Pharmacy Times

JANUARY 9, 2024

Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.

FDA 145

FDA 145

STAT

JANUARY 9, 2024

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home th

FDA 145

FDA 145

Pharmacy Times

JANUARY 9, 2024

Patients who received telemedicine alone had worse glycemic control and less improvement in hemoglobin A1c levels.

144

144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

JANUARY 9, 2024

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear. The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P.

143

143

Pharmacy Times

JANUARY 9, 2024

Most important of all, we gained a new level of empathy and understanding for patients diagnosed with diabetes whose diagnosis requires that they are constantly mindful and attentive to the balance of diet, exercise, and lifestyle in their day-to-day lives.

144

144

Fierce Pharma

JANUARY 9, 2024

Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. | Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.

139

139

STAT

JANUARY 9, 2024

Few public health challenges have been more daunting and persistent than the opioid crisis, which started because of egregious conduct by opioid manufacturers and now is driven by an influx of fentanyl. In my home state of New Hampshire — which has been at the forefront of this heartbreaking epidemic for more than a decade — too many promising futures have been snatched away.

141

141

Drug Topics

JANUARY 9, 2024

In August, the FDA issued a 1-year stabilization policy on the final enhanced drug distribution security requirements under the DSCSA. What exactly does that mean for pharmacists?

FDA 138

FDA 138

STAT

JANUARY 9, 2024

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain. Perhaps the most important thing he’s telling investors at the J.P.

136

136

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 9, 2024

Last August, Blue Shield of California made headlines when it rev | As the market shifts toward greater transparency, Express Scripts has rolled out multiple programs in the past year that aim to address some of the central criticisms of the industry.

130

130

STAT

JANUARY 9, 2024

SAN FRANCISCO  — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.  Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P.

Insurance 127

Insurance 127

pharmaphorum

JANUARY 9, 2024

Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.

125

125

European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. This article highlights the manifold applications of AI, particularly cutting-edge image recognition and computer vision systems, which profoundly impact quality control.

FDA 122

FDA 122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 9, 2024

The accepted sBLA comes after phase 3 clinical trial results which demonstrated better overall survival, progression-free survival, and confirmed overall response rate than chemotherapy in patients with cervical cancer.

Chemotherapy 122

Chemotherapy FDA 122

pharmaphorum

JANUARY 9, 2024

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

119

119

Pharmacy Times

JANUARY 9, 2024

Anaïs Webster Mennuti, PharmD and Kristin Speer, PharmD, BCPS, discuss their new documentary that highlights the understaffed and overwhelmed reality of retail pharmacy.

121

121

Fierce Healthcare

JANUARY 9, 2024

Pharmacological interventions demonstrate fewer disparities in obesity treatment than behavioral and surgical treatment, a new literature review has found. | While most behavioral and surgical treatment studies reveal disparities in weight loss and clinical outcomes, pharmacological studies reveal minimal to no evidence of disparities and favorable outcomes for minorities.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JANUARY 9, 2024

Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (C | Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (CLDN) positive.

FDA 118

FDA 118

Drug Store News

JANUARY 9, 2024

NACDS' new TV ad says the “clock is ticking” for vital Medicare and Medicaid reforms needed to protect Americans, communities and pharmacies.

116

116

PharmExec

JANUARY 9, 2024

Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.

115

115

Drug Store News

JANUARY 9, 2024

Albertsons' net sales and other revenue was $18.6 billion during the third quarter compared to $18.2 billion during the prior year period.

116

116

Drug Topics

JANUARY 9, 2024

In this conversation from the Healthcare Advocate Summit, Ned Woody, senior associate director of field reimbursement at Daiichi Sankyo Inc. - Oncology, discusses the disruptive impact that these programs have on patients.

112

112

Drug Store News

JANUARY 9, 2024

The personal care collection, which features deodorant, deodorant and body spray, body wash, shampoo and conditioner, is inspired by the cookies, the brand noted.

112

112

Drug Topics

JANUARY 9, 2024

Placing telepharmacy at the forefront of outdated workflows could transform the traditional pharmacy setting.

112

112

pharmaphorum

JANUARY 9, 2024

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug candidates for cancer.

FDA 111

FDA 111

Drug Topics

JANUARY 9, 2024

Tyler Woods, PharmD, was joined by Ajay Mehra, chief financial officer and cofounder of UGO Rx, and Scott Cady, PharmD, during the Total Pharmacy Solutions Summit Fall 2023 to discuss how pharmacists can maximize opportunities to improve their stores.

112

112

pharmaphorum

JANUARY 9, 2024

Amazon has launched an initiative with Omada Health at JPM that makes it easier for patients to discover and enrol in digital health benefit programmes

110

110

Drug Store News

JANUARY 9, 2024

Cline will be featured as the face of the Revlon brand and products and across a marketing mix that includes in-store displays at retailer events and global campaigns.

106

106

pharmaphorum

JANUARY 9, 2024

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos Phil.

110

110

Fierce Healthcare

JANUARY 9, 2024

To diversify its revenue stream, the Philadelphia-based nonprofit wants to make health insurance a much larger part of its business.

Insurance 105

Insurance 105

pharmaphorum

JANUARY 9, 2024

Discover how AI innovations are revolutionising the engagement between life sciences companies and healthcare professionals. Learn about the latest advancements and their impact on the industry.

106

106

Fierce Healthcare

JANUARY 9, 2024

Walgreens has agreed to a $360 million settlement in arbitration dispute with Humana, the company disclosed late last week. | Walgreens has agreed to a $360 million settlement in arbitration dispute with Humana, the company disclosed late last week.

105

105